It is now available under a Creative Commons Attribution 4.0 International license, CC-BY, The Author(s)
Both medications work by helping the pancreas make more insulin
Physical examinations (including neurological assessments) are conducted at screening, and weeks 52, 104, and 156
OHP2-induced H3K9la creates a metabolic link, fueling aerobic glycolysis for AD therapy
This condition involves significant slowing or complete paralysis of stomach muscle function, preventing proper food movement into the small intestine
This initial loss is often a mix of water weight and fat loss, but it provides important momentum for continuing treatment